Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Sawyer Timothy
 2. Date of Event Requiring Statement (Month/Day/Year)
11/08/2006		 3. Issuer Name and Ticker or Trading Symbol
BARR PHARMACEUTICALS INC [BRL]
(Last)
(First)
(Middle)
BARR PHARMACEUTICALS, INC, 400 CHESTNUT RIDGE RD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Sr VP, European Commer Develop
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

WOODCLIFF LAKE, NJ 07677		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 157
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Options 10/24/2001 08/08/2011 Common Stock 2,707 $ 36.3289 D  
Incentive Stock Options   (1) 08/07/2012 Common Stock 11,278 $ 26.5822 D  
Incentive Stock Options 07/30/2006 07/30/2013 Common Stock 2,310 $ 43.34 D  
Non-Qualifed Stock Options   (2) 07/30/2013 Common Stock 20,190 $ 43.34 D  
Non-Qualifed Stock Options   (3) 08/04/2014 Common Stock 7,144 $ 35.01 D  
Incentive Stock Options 08/04/2007 08/04/2014 Common Stock 2,856 $ 35.01 D  
Stock Appreciation Rights   (4) 07/27/2015 Common Stock 15,872 $ 46.99 D  
Incentive Stock Options with Tandem SARs 07/27/2008 07/27/2015 Common Stock 2,128 $ 46.99 D  
Stock Appreciation Rights   (5) 07/26/2016 Common Stock 12,951 $ 48.8 D  
Incentive Stock Options with Tandem SARs 07/26/2009 07/26/2016 Common Stock 2,049 $ 48.8 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Sawyer Timothy
BARR PHARMACEUTICALS, INC
400 CHESTNUT RIDGE RD
WOODCLIFF LAKE, NJ 07677		       Sr VP, European Commer Develop  

Signatures

S/S William T McKee as Attorney-in-Fact for Timothy Sawyer 11/17/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) 3,760 vest 8/7/2003 3,759 vest 8/7/2004 3,759 vest 8/7/2005
(2) 7,499 vest 7/30/2004 7,498 vest 7/30/2005 5,193 vest 7/30/2006
(3) 5,000 vest 8/4/2006 2,144 vest 8/4/2007
(4) 6,000 vest 07/27/2006 6,000 vest 07/27/2007 3,872 vest 07/27/2008
(5) 5,000 vest 7/26/2007 5,000 vest 7/26/2008 2,951 vest 7/26/2009

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.